Skip to main content

Chemours places three on leave during review

1st March 2024

Submitted by:

Andrew Warmington

The board of Chemours has put CEO Mark Newman, CFO Jonathan Lock and principal accounting officer Camela Wisel on administrative leave pending the completion of an internal review by independent counsel that the board’s audit committee is overseeing.

The scope of the review includes the processes for reviewing reports made to the company’s ethics hotline, practices for managing working capital, including the related impact on metrics within the incentive plans, certain non-GAAP metrics included in filings made with the Securities & Exchange Commission (SEC) and other related disclosures.

As a result, Chemours is evaluating potential material weaknesses in its internal control over financial reporting as of 31 December 2023, with respect to maintaining effective controls related to the control environment. This includes the effectiveness of the ‘tone at the top’ set by some senior management figures, and information and communication components of the COSO internal control framework.

Denise Dignam and Matt Abbott are acting as interim CEO and CFO respectively. Dignam has been with the company since 2015 and has served in multiple senior roles, most recently as president of Titanium Technologies. Abbott joined from PwC in 2019 and has been chief enterprise transformation officer since June 2023.

Lock, who was previously chief development officer, had only become CFO following the resignation of Sameer Ralhan in June 2023. Ralhan’s was the third departure in quick succession at Chemours, following those of Edwin Sparks, president of Titanium Technologies and Chemical Solutions business on 31 March and Alisha Bellezza, president of Thermal & Specialized Solutions on 31 May of that year.

This all came after the company announced a delay to its Q4 and full-year 2023 results, which were due to be issued on 29 February. It has filed a Form 12b-25 with the SEC and will announce a revised date at a point as yet unknown. The Q4 results had already been delayed from 13 to 29 February and the company’s share price fell by 45% in that time frame.

Reuters quoted Barclays analyst Michael Leithead as saying: “What we think many perceived as likely a relatively minor accounting hang-up two weeks ago now appears wider, longer and with more ramifications than the market initially believed.”

Unaudited preliminary estimates suggest that sales fell from $6.8 billion to about $6.0 billion in 2023, with a net loss of $225-235million, compared to net income of $578 million. This includes $746 million of pre-tax litigation settlements mainly related to PFAS and $153 million of restructuring, asset-related and other charges, offset by a $106 million net pre-tax gain associated with the 2023 sale of the Glycolic Acid business.

The fall in sales is primarily attributable to lower volumes in Titanium Technologies and in the Advanced Materials portfolio of the Advanced Performance Materials business. This was partially offset by increased pricing and volumes in Thermal & Specialized Solutions.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington